跳至主要内容
临床试验/IRCT20160606028304N2
IRCT20160606028304N2已完成4 期

Efficacy of Solifenacin and trospium chloride on neurogenic bladder after stroke: a multicentric three arms placebo-controlled trial

Tabriz University of Medical Sciences0 个研究点目标入组 201 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
201

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Stroke diagnosis patients
  • Normal cognitive function
  • Lower urinary tract symptomes
  • Patients with CVA should be ambulatory, able to communicate, and record a voiding diary
  • age =18 years

排除标准

  • Evidence of brain stem or bilateral signs on examination
  • Mental disorders according to the patient's own statement
  • Having history of LUTS surgery, pelvic and urologic surgery, or trauma
  • Other severe neurological disease including dementia
  • Severe psychiatric disease
  • Prostate cancer
  • Patients who refuse consent
  • Abnormal liver function
  • severe constipation
  • patiensts with previous history of hypersensitivity reaction to anticholinergics or closed anterior chamber glaucoma

研究者

相似试验